epristeride has been researched along with Adenoma, Prostatic in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballard, S; Blagg, J; Fox, D; Kenny, B | 1 |
| Baston, E; Hartmann, RW | 1 |
| Aggarwal, S; Bhardwaj, TR; Kumar, M; Thareja, S | 1 |
| Hua, LX; Ju, XB; Li, J; Wu, HF; Zhang, W | 1 |
| Jin, J; Kong, CZ; Li, NC; Na, YQ; Qiu, SP; Song, YS; Sun, G; Sun, YC; Sun, YH; Wang, XF; Wu, SL; Ye, ZQ | 1 |
| Berthaut, I; Cussenot, O; Mestayer, C; Mowszowicz, I; Portois, MC | 1 |
| Collins, AT; Neal, DE; Robinson, EJ; Robson, CN | 1 |
| Sun, ZY; Tu, ZH; Wang, MY; Wu, HY | 1 |
| Qi, XD; Sun, HZ; Tu, ZH; Wu, SF | 1 |
| Sun, HZ; Tu, ZH; Wu, HY; Wu, SF | 1 |
| Qian, LH; Tu, ZH; Wang, XL | 1 |
1 review(s) available for epristeride and Adenoma, Prostatic
| Article | Year |
|---|---|
Pharmacological options in the treatment of benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlled Clinical Trials as Topic; Endothelins; Enzyme Inhibitors; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Structure-Activity Relationship | 1997 |
2 trial(s) available for epristeride and Adenoma, Prostatic
| Article | Year |
|---|---|
[The clinical efficacy of epristeride in the treatment of benign prostatic hyperplasia].
Topics: Aged; Aged, 80 and over; Androstadienes; Humans; Male; Middle Aged; Prostatic Hyperplasia; Treatment Outcome | 2002 |
[Comparison of different drugs on the treatment of benign prostate hyperplasia].
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Androstadienes; Double-Blind Method; Doxazosin; Enzyme Inhibitors; Finasteride; Follow-Up Studies; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Plant Extracts; Prazosin; Prostate; Prostatic Hyperplasia; Quality of Life; Secale; Sulfonamides; Tamsulosin; Treatment Outcome | 2007 |
8 other study(ies) available for epristeride and Adenoma, Prostatic
| Article | Year |
|---|---|
N-substituted 4-(5-indolyl)benzoic acids. Synthesis and evaluation of steroid 5alpha-reductase type I and II inhibitory activity.
Topics: Animals; Benzoates; Cell Line; Cells, Cultured; Cholestenone 5 alpha-Reductase; Humans; Inhibitory Concentration 50; Male; Models, Chemical; Oxidoreductases; Prostatic Hyperplasia; Rats | 1999 |
Self organizing molecular field analysis on a series of human 5alpha-reductase inhibitors: unsaturated 3-carboxysteroid.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Computer Simulation; Enzyme Activation; Enzyme Inhibitors; Humans; Male; Molecular Structure; Prostatic Hyperplasia; Quantitative Structure-Activity Relationship | 2009 |
Pharmacological and molecular evidence for the expression of the two steroid 5 alpha-reductase isozymes in normal and hyperplastic human prostatic cells in culture.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Androstadienes; Base Sequence; Benzoquinones; Blotting, Northern; Cell Line; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epithelial Cells; Epithelium; Fibroblasts; Finasteride; Gene Expression Regulation, Enzymologic; Humans; Isoenzymes; Male; Oligonucleotides; Polymerase Chain Reaction; Prostate; Prostatic Hyperplasia; RNA, Messenger | 1997 |
Effects of a new 5 alpha reductase inhibitor (epristeride) on human prostate cell cultures.
Topics: 5-alpha Reductase Inhibitors; Adult; Androstadienes; Cell Division; Cells, Cultured; Dihydrotestosterone; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Epithelium; Humans; Immunohistochemistry; Male; Polymerase Chain Reaction; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Hyperplasia; RNA, Messenger; Testosterone; Thymidine; Transcription, Genetic; Transforming Growth Factor beta | 1997 |
The mechanism of epristeride against benign prostatic hyperplasia.
Topics: Androstadienes; Animals; Apoptosis; Cell Culture Techniques; Cell Size; Dihydrotestosterone; DNA Fragmentation; Electrophoresis, Agar Gel; Enzyme Inhibitors; Epithelium; Flow Cytometry; Immunohistochemistry; Male; Microscopy; Microspectrophotometry; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley | 1999 |
Effect of epristeride on the expression of IGF-1 and TGF-beta receptors in androgen-induced castrated rat prostate.
Topics: Androgens; Androstadienes; Animals; Enzyme Inhibitors; Insulin-Like Growth Factor I; Male; Orchiectomy; Prostate; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Receptor, IGF Type 1; Receptors, Transforming Growth Factor beta; Transforming Growth Factor beta | 2001 |
Inhibition of cultured rat prostatic epithelial cell growth by epristeride in vitro.
Topics: 5-alpha Reductase Inhibitors; Androstadienes; Animals; Cell Division; Cells, Cultured; Epidermal Growth Factor; Epithelial Cells; ErbB Receptors; Insulin-Like Growth Factor I; Male; Prostate; Prostatic Hyperplasia; Rats; Receptor, IGF Type 1; RNA, Messenger | 2001 |
Atrophy and apoptosis in ventral prostate of rats induced by 5alpha-reductase inhibitor, epristeride.
Topics: 5-alpha Reductase Inhibitors; Acid Phosphatase; Androstadienes; Animals; Apoptosis; Atrophy; Biomarkers; Male; Organ Size; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley | 2001 |